General Information of the Compound
Compound ID
CP0031347
Compound Name
2-((4-(pyridin-2-yl)piperazin-1-yl)methyl)-1H-benzo[d]imidazole
    Show/Hide
Synonyms
2-[4-(2-Pyridyl)piperazin-1-ylmethyl]-1H-benzimidazole maleate
ABT-724
    Show/Hide
Structure
Formula
C17H19N5
Molecular Weight
293.374
Canonical SMILES
C(N1CCN(CC1)c1ccccn1)c1nc2ccccc2[nH]1
    Show/Hide
InChI
InChI=1S/C17H19N5/c1-2-6-15-14(5-1)19-16(20-15)13-21-9-11-22(12-10-21)17-7-3-4-8-18-17/h1-8H,9-13H2,(H,19,20)
    Show/Hide
InChIKey
FRPJGTNLZNXQEX-UHFFFAOYSA-N
Physicochemical Property
logP
2.2801
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
48.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5025739
SID: 14849264
ChEMBL ID
CHEMBL440687
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 12.4 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 ~ 12.4 nM
2 Ki = 167 nM
3 Ki ~ 46.8 nM
4 Ki ~ 57.5 nM
5 Ki ~ 63.6 nM
Protein ID: PT02684, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
EC50 = 13.7 nM
   TI
   LI
   LO
   TS
2
EC50 = 14.3 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( ABT-724 )
Drug Name ABT-724
Indication
Erectile dysfunction
Discontinued in Phase 2
Target(s)
Dopamine D4 receptor (D4R)
Agonist